Corporate News – Market Activity Update
Abcellera Biologics (ABCL)
- Price movement: Up 4.53 % during the 24‑hour period ending 08:21 AM Central Europe, Friday 23 Oct 2026.
- Current price: USD 11.37 on major exchanges.
- Shares outstanding: 324 million.
- Market capitalization: USD 4.0 billion.
- 24‑hour trading volume: USD 39.2 million.
- Monthly change: Down 3.24 % since the end of the previous month.
- 200‑day simple moving average: USD 6.56.
- 52‑week range: Highest USD 15.02 (30 Sep 2026); lowest USD 2.74 (5 Feb 2026).
Related Stocks – 24‑Hour Performance
| Ticker | Price change | Current price | Market cap (CAD) | P/E ratio |
|---|---|---|---|---|
| TFPM.TO | +0.14 % | CAD 41.12 | CAD 6.5 bn | 15.44 |
| GRGD.TO | +2.73 % | CAD 57.27 | CAD 6.5 bn | – |
| EMP-A.TO | +3.16 % | CAD 51.88 | CAD 6.3 bn | 52.06 |
| EFN.TO | +0.70 % | CAD 21.52 | CAD 6.1 bn | 20.6 |
| FSV.TO | +7.41 % | CAD 206.06 | CAD 6.1 bn | 38.7 |
Company Overview
AbCellera Biologics Inc. is a Canadian pharmaceutical company headquartered in Vancouver. It focuses on the discovery and development of next‑generation therapeutic antibodies. The company employs proprietary immunization, microfluidics, high‑throughput imaging, genomics, computational methods, and laboratory automation to create advanced therapies. AbCellera Biologics trades on the Nasdaq exchange and provides additional information on its website: www.abcellera.com .
